Jennifer Doudna, a pioneer of the revolutionary genome-editing technology, reflects on how 2015 became the most intense year of her career — and what she's learned.
A statement about the U.S. Court of Appeals decision on the University of California's patent interference claim before the Patent Trial and Appeal Board b by Charles F. Robinson, Office of General Counsel, UC Office of the President.
1.7 million treatments of semisynthetic artemisinin have shipped to Africa, where they will treat malaria sufferers in Burkina Faso, Burundi, Democratic Republic of the Congo, Liberia, Niger and Nigeria over the next few months. This shipment is the culmination of a 13-year project in the lab of CBE professor Jay Keasling. Enough semisynthetic artemisinin has been produced for 70 million treatments, and the capacity exists to produce 100-150 million treatments annually.
UC Berkeley scientists have proved a fundamental relationship between energy and time that sets a “quantum speed limit” on processes ranging from quantum computing and tunneling to optical switching.